SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-027140
Filing Date
2021-05-17
Accepted
2021-05-17 17:01:56
Documents
65
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0321_adialpharma.htm 10-Q 521382
2 CERTIFICATION f10q0321ex31-1_adialpharma.htm EX-31.1 11151
3 CERTIFICATION f10q0321ex31-2_adialpharma.htm EX-31.2 11174
4 CERTIFICATION f10q0321ex32-1_adialpharma.htm EX-32.1 4188
5 CERTIFICATION f10q0321ex32-2_adialpharma.htm EX-32.2 4200
  Complete submission text file 0001213900-21-027140.txt   3395506

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE adil-20210331.xml EX-101.INS 388457
7 XBRL SCHEMA FILE adil-20210331.xsd EX-101.SCH 59957
8 XBRL CALCULATION FILE adil-20210331_cal.xml EX-101.CAL 28490
9 XBRL DEFINITION FILE adil-20210331_def.xml EX-101.DEF 219832
10 XBRL LABEL FILE adil-20210331_lab.xml EX-101.LAB 462399
11 XBRL PRESENTATION FILE adil-20210331_pre.xml EX-101.PRE 235125
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38323 | Film No.: 21932012
SIC: 2834 Pharmaceutical Preparations